Skip to main content

Advertisement

SpringerLink
Log in

Immunohistochemical and molecular analysis of an α-fetoprotein-producing cervical adenocarcinoma with clear cell morphology

  • Original Paper
  • Published:
Medical Molecular Morphology Aims and scope Submit manuscript

Abstract

Adenocarcinomas with clear cell morphology may be associated with elevated serum alpha-fetoprotein levels in various organs. We report the case of an alpha-fetoprotein-producing cervical adenocarcinoma with clear cell morphology and compare it immunohistochemically, molecularly, and virologically with cervical clear cell carcinoma, gastric-type mucinous carcinoma, and ovarian clear cell carcinoma. A 51-year-old Japanese woman was initially diagnosed with cervical clear cell carcinoma. The tumor was resistant to standard surgery, radiotherapy, and chemotherapy. Serum carcinoembryonic antigen and alpha-fetoprotein were elevated. The tumor was immunohistochemically positive for alpha-fetoprotein, human chorionic gonadotropin, cytokeratin 20, spalt-like transcription factor 4, glypican 3, MUC6, and HIK1083. Gene panel testing revealed CCNE1 amplification, CDKN2A loss, and TP53 R282W. We compared the present case with 120 ovarian clear cell carcinoma cases using a tissue microarray. Only one case (0.8%) showed very limited immunohistochemical positivity for alpha-fetoprotein. Of the 54 cases in which serum carcinoembryonic antigen was measured, only one (1.9%) was elevated (19.9 ng/mL). We diagnosed the case as alpha-fetoprotein-producing cervical gastric-type mucinous carcinoma with enteroblastic differentiation. In conclusion, alpha-fetoprotein-producing cervical adenocarcinoma is a rare but aggressive tumor. Clinicians and pathologists should be aware of this unfamiliar tumor, its diagnostic clues, prognostic markers, and treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen A, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA (2018) Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas. Am J Surg Pathol 42:989–1000. https://doi.org/10.1097/PAS.0000000000001090

    Article  PubMed  PubMed Central  Google Scholar 

  2. Jenkins D, Molijn A, Kazem S, Pirog EC, Alemany L, de Sanjosé S, Dinjens Wm Quint W (2020) Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study. Int J Cancer 147:2526–2536. https://doi.org/10.1002/ijc.33124

    Article  CAS  PubMed  Google Scholar 

  3. Lu S, Shen D, Zhao Y, Kang N, Wang X (2019) Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases. Diagn Pathol 14:72. https://doi.org/10.1186/s13000-019-0852-y

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wang D, Zhao C, Fu L, Liu Y, Zhang W, Tl Xu (2019) Primary clear cell adenocarcinoma of the cervix: a clinical analysis of 18 cases without exposure to diethylstilbestrol. Obstet Gynecol Int 2019:9465375. https://doi.org/10.1155/2019/9465375

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hodgson A, Olkhov-Mitsel E, Howitt BE, Nucci MR, Parra-Herran C (2019) International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome. J Clin Pathol 72:347–353. https://doi.org/10.1136/jclinpath-2018-205632

    Article  PubMed  Google Scholar 

  6. Reich O, Tamussino K, Lahousen M, Pickel H, Haas J, Winter R (2000) Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol 76:331–335. https://doi.org/10.1006/gyno.1999.5700

    Article  CAS  PubMed  Google Scholar 

  7. El-Bahrawy M (2010) Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract. Eur J Cancer 46:1317–1322. https://doi.org/10.1016/j.ejca.2010.01.028

    Article  CAS  PubMed  Google Scholar 

  8. Hirajima S, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Ikoma H, Otsuji E (2013) Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer. World J Gastroenterol 19:6055–6061. https://doi.org/10.3748/wjg.v19.i36.6055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Matsueda K, Yamamoto H, Yoshida Y, Notohara K (2006) Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP). J Gastroenterol 41:1011–1019. https://doi.org/10.1007/s00535-006-1889-8

    Article  PubMed  Google Scholar 

  10. Cappetta A, Bergamo F, Mescoli C, Lonardi S, Rugge M, Zagonel V (2012) Hepatoid adenocarcinoma of the colon: what should we target? Pathol Oncol Res 18:93–96. https://doi.org/10.1007/s12253-011-9424-5

    Article  PubMed  Google Scholar 

  11. Morimoto A, Sudo T, Sakuma T, Yasudad M, Fujiwara K (2014) Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma simulating fetal gut in a postmenopausal woman. Gynecol Oncol Case Rep 8:24–26. https://doi.org/10.1016/j.gynor.2014.03.001

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chao W-T, Liu C-H, Lai C-R, Chen Y, Chuang C, Wang P (2018) Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review. J Ovarian Res 11:52. https://doi.org/10.1186/s13048-018-0426-8

    Article  PubMed  PubMed Central  Google Scholar 

  13. Toyoda S, Uchiyama T, Morita K, Ishida E, Sugiura A, Kita T, Ohbayashi C (2019) Cytological diagnosis of a rare case of α-fetoprotein producing gastric-type adenocarcinoma of the uterine cervix. Cytopathology 30:440–443. https://doi.org/10.1111/cyt.12688

    Article  PubMed  Google Scholar 

  14. Kato K, Suzuka K, Osaki T, Itami M, Tanaka N (2007) Primary hepatoid adenocarcinoma of the uterine cervix. Int J Gynecol Cancer 17:1150–1154. https://doi.org/10.1111/j.1525-1438.2007.00901.x

    Article  CAS  PubMed  Google Scholar 

  15. Maida Y, Kyo S, Takakura M, Kanaya T, Inoue M (1998) Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein. Gynecol Oncol 71:133–136. https://doi.org/10.1006/gyno.1998.5119

    Article  CAS  PubMed  Google Scholar 

  16. Tsung JSH, Yang PS (2004) Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report. Eur J Gynaecol Oncol 25:745–748

    CAS  PubMed  Google Scholar 

  17. Maru Y, Tanaka N, Ohira M, Itami M, Hippo Y, Hl N (2017) Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis. Gynecol Oncol 144:377–383. https://doi.org/10.1016/j.ygyno.2016.11.045

    Article  CAS  PubMed  Google Scholar 

  18. Nakamura A, Yamaguchi K, Minamiguchi S, Murakami R, Abiko K, Hamanishi J, Kondoh E, Baba T, Mandai M, Matsumura N (2019) Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification. Med Mol Morphol 52:52–59. https://doi.org/10.1007/s00795-018-0202-2

    Article  CAS  PubMed  Google Scholar 

  19. Murakami T, Yao T, Mitomi H, Morimoto T, Ueyama H, Matsumoto K, Saito T, Osada T, Nagahara A, Watanabe S (2016) Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer 19:498–507. https://doi.org/10.1007/s10120-015-0497-9

    Article  CAS  PubMed  Google Scholar 

  20. Furuya Y, Wakahara T, Akimoto H, Kishimoto T, Hiroshima K, Yanagie H, Yasuhara H (2011) Clear cell adenocarcinoma with enteroblastic differentiation of the ascending colon. J Clin Oncol 29:e647–e649. https://doi.org/10.1200/JCO.2011.34.9670

    Article  PubMed  Google Scholar 

  21. Li N, Bai C, Zhang R, Mac L, Rend ZJ, Fu Z, Zhaoa L (2021) Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer. Transl Oncol 14:101004. https://doi.org/10.1016/j.tranon.2020.101004

    Article  CAS  PubMed  Google Scholar 

  22. Lu J, Ding Y, Chen Y, Jiang J, Chen Y, Huang Y, Wu M, Li C, Kong M, Zhao W, Wang H, Zhang J, Li Z, Lu Y, Yu X, Jin K, Zhou D, Zhou T, Teng F, Zhang H, Zhou Z, Wang H, Teng L (2021) Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets. Nat Commun 12:3946. https://doi.org/10.1038/s41467-021-24170-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Li W, Li Q, Yu Y, Wang Y, Chen E, Chen Y, Wang Z, Cui Y, Lui T (2020) Effect of immune checkpoint inhibitors plus chemotherapy on advanced gastric cancer patients with elevated serum AFP or hepatoid adenocarcinoma. Cancer Manag Res 12:11113–11119. https://doi.org/10.2147/CMAR.S276969

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank Editage (www.editage.jp) for English language editing.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan

    Shu Kuriyama, Mitsutake Yano, Sumika Zaitsu & Kaei Nasu

  2. Department of Pathology, Saitama Medical University International Medical Centre, Saitama, Japan

    Mitsutake Yano & Masanori Yasuda

  3. Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Oita, Japan

    Takahiro Kusaba & Haruto Nishida

  4. Division of Obstetrics and Gynecology, Support System for Community Medicine, Faculty of Medicine, Oita University, Oita, Japan

    Kaei Nasu

Authors
  1. Shu Kuriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsutake Yano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takahiro Kusaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sumika Zaitsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haruto Nishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masanori Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kaei Nasu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsutake Yano.

Ethics declarations

Conflicts of interest

The authors declare no conflicts of interest associated with this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuriyama, S., Yano, M., Kusaba, T. et al. Immunohistochemical and molecular analysis of an α-fetoprotein-producing cervical adenocarcinoma with clear cell morphology. Med Mol Morphol 56, 20–27 (2023). https://doi.org/10.1007/s00795-022-00336-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00795-022-00336-7

Keywords

Search

Navigation